Litigation
Novartis Pharmaceuticals Corp. v. HEC Pharm Co., Ltd.
Certiorari denied22-671
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Petition for certiorari from the Federal Circuit's invalidation of the '405 patent; emergency stay of mandate was granted by Chief Justice Roberts on 2022-09-29; certiorari was denied (143 S. Ct. 1748).
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).